PubRank

Christian Kupatt

Author PubWeight™ 54.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014 9.33
2 An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003 3.19
3 Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2013 2.08
4 Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008 1.77
5 Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 2003 1.62
6 Three-dimensional printing of models for preoperative planning and simulation of transcatheter valve replacement. Ann Thorac Surg 2012 1.46
7 Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - A multicenter phase I and safety study -. Circ J 2010 1.46
8 Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart 2014 1.43
9 Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest 2013 1.32
10 Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation 2013 1.31
11 RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 2010 1.14
12 Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation 2009 1.07
13 Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin Res Cardiol 2012 1.06
14 Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention 2014 1.05
15 Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004 1.03
16 Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol 2013 1.03
17 Accuracy of dynamic computed tomography adenosine stress myocardial perfusion imaging in estimating myocardial blood flow at various degrees of coronary artery stenosis using a porcine animal model. Invest Radiol 2012 0.98
18 Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation 2011 0.95
19 Gene therapy for ischemic heart disease. Expert Opin Biol Ther 2011 0.94
20 Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia. PLoS One 2013 0.92
21 Feasibility of dynamic CT-based adenosine stress myocardial perfusion imaging to detect and differentiate ischemic and infarcted myocardium in an large experimental porcine animal model. Int J Cardiovasc Imaging 2014 0.89
22 Sick sinus syndrome in HCN1-deficient mice. Circulation 2013 0.89
23 Role of PARP on iNOS pathway during endotoxin-induced acute lung injury. Intensive Care Med 2004 0.88
24 Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia. Ann N Y Acad Sci 2010 0.86
25 Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury. Respir Res 2004 0.85
26 SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization. Stem Cells 2013 0.84
27 Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheter Cardiovasc Interv 2004 0.84
28 NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37. Stem Cells 2010 0.83
29 Effectiveness of automated quantification of pulmonary perfused blood volume using dual-energy CTPA for the severity assessment of acute pulmonary embolism. Invest Radiol 2013 0.83
30 Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection. Ann N Y Acad Sci 2012 0.82
31 Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovasc Res 2005 0.82
32 Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol 2004 0.81
33 Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein. Eur Heart J 2005 0.80
34 Adjuvant early and late cardioprotective therapy: access to the heart. Cardiovasc Res 2012 0.78
35 Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis. Expert Opin Biol Ther 2015 0.78
36 Partial inferior sternotomy and deep hypothermic circulatory arrest for rescue of a failed TAVI case: what does constitute 'inoperable'? Thorac Cardiovasc Surg 2013 0.77
37 Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis. Cancer Res 2011 0.77
38 Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells. J Cell Mol Med 2015 0.77
39 Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth. Hum Gene Ther 2009 0.77
40 Therapeutic angiogenesis/arteriogenesis in the chronic ischemic rabbit hindlimb: effect of venous basic fibroblast growth factor retroinfusion. Endothelium 2003 0.77
41 Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Curr Opin Cardiol 2014 0.76
42 Adeno-associated viral vector 2.9 thymosin ß4 application attenuates rejection after heart transplantation: results of a preclinical study in the pig. Transplantation 2014 0.76
43 Transcatheter aortic valve implantation in dialysis patients. Nephron Clin Pract 2012 0.76
44 Angiogenetic potential of Ad2/Hif-1α/VP16 after regional application in a preclinical pig model of chronic ischemia. Curr Vasc Pharmacol 2013 0.76
45 Nonviral intercellular adhesion molecule-1 small interfering ribonucleic acid sequences transfection in vivo how ultrasound bursts into therapy. J Am Coll Cardiol 2010 0.76
46 Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance. Can J Cardiol 2013 0.75
47 Hemodynamic and vascular effects of ventricular sourcing by stent-based ventricle to coronary artery bypass in patients with multivessel disease undergoing coronary artery bypass surgery. Circulation 2005 0.75
48 Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2015 0.75
49 Transcatheter aortic valve implantation in aortic coarctation. Thorac Cardiovasc Surg 2012 0.75
50 [Role of bone marrow-derived CD133+ stem cells in cardiac regeneration: from experimental to clinical trials]. G Ital Cardiol (Rome) 2014 0.75
51 Partial avulsion of prosthetic aortic valve caused by S. epidermidis infection resulting in a giant false aneurysm of the complete thoracic aorta. Int J Cardiol 2010 0.75
52 Transcatheter aortic-valve endocarditis confirmed by transesophageal echocardiography. Circulation 2013 0.75
53 Balloon valvuloplasty for treatment of cardiogenic shock in the era of surgical valve replacement and TAVI. Intern Emerg Med 2013 0.75
54 Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway. Expert Opin Biol Ther 2015 0.75
55 Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nat Commun 2017 0.75